No black box warning on record for Diclofenac Sodium Topical Solution

As of the latest FDA labeling reviewed, Diclofenac Sodium Topical Solution (DICLOFENAC SODIUM TOPICAL SOLUTION) does not carry a black box warning. Standard warnings and precautions still apply — see the full Diclofenac Sodium Topical Solution medicine page for the complete safety profile.

Other warnings & precautions

5.1 Cardiovascular Thrombotic Events Clinical trials of several COX-2 selective and nonselective NSAIDs of up to three years duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, including myocardial infarction (MI), and stroke, which can be fatal. Based on available data, it is unclear that the risk for CV thrombotic events is similar for all NSAIDs. The relative

No black box warning on record for Diclofenac Sodium Topical Solution

Other warnings & precautions

5.1 Cardiovascular Thrombotic Events Clinical trials of several COX-2 selective and nonselective NSAIDs of up to three years duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, including myocardial infarction (MI), and stroke, which can be fatal. Based on available data, it is unclear that the risk for CV thrombotic events is similar for all NSAIDs. The relative

Diclofenac Sodium Topical Solution Black Box Warning

No black box warning on record for Diclofenac Sodium Topical Solution

Other warnings & precautions

Diclofenac Sodium Topical Solution Black Box Warning

No black box warning on record for Diclofenac Sodium Topical Solution

Other warnings & precautions